| Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2 Y Yokota, A Mansouri, S Mori, S Sugawara, S Adachi, SI Nishikawa, ... Nature 397 (6721), 702-706, 1999 | 1055 | 1999 |
| Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients TZ Tan, QH Miow, Y Miki, T Noda, S Mori, RYJ Huang, JP Thiery EMBO molecular medicine 6 (10), 1279-1293, 2014 | 717 | 2014 |
| Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells T Baba, PA Convery, N Matsumura, RS Whitaker, E Kondoh, T Perry, ... Oncogene 28 (2), 209-218, 2009 | 539 | 2009 |
| A bistable Rb–E2F switch underlies the restriction point G Yao, TJ Lee, S Mori, JR Nevins, L You Nature cell biology 10 (4), 476-482, 2008 | 532 | 2008 |
| An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor … RYJ Huang, MK Wong, TZ Tan, KT Kuay, AHC Ng, VY Chung, YS Chu, ... Cell death & disease 4 (11), e915-e915, 2013 | 462 | 2013 |
| Anchorage-independent cell growth signature identifies tumors with metastatic potential S Mori, JT Chang, ER Andrechek, N Matsumura, T Baba, G Yao, JW Kim, ... Oncogene 28 (31), 2796-2805, 2009 | 404 | 2009 |
| Role of Id family proteins in growth control Y Yokota, S Mori Journal of cellular physiology 190 (1), 21-28, 2002 | 315 | 2002 |
| An E2F1-dependent gene expression program that determines the balance between proliferation and cell death TC Hallstrom, S Mori, JR Nevins Cancer cell 13 (1), 11-22, 2008 | 298 | 2008 |
| Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer TZ Tan, QH Miow, RYJ Huang, MK Wong, J Ye, JA Lau, MC Wu, ... EMBO molecular medicine 5 (7), 1051-1066, 2013 | 238 | 2013 |
| The genomic analysis of lactic acidosis and acidosis response in human cancers JLY Chen, JE Lucas, T Schroeder, S Mori, J Wu, J Nevins, M Dewhirst, ... PLoS genetics 4 (12), e1000293, 2008 | 235 | 2008 |
| Lactation defect in mice lacking the helix–loop–helix inhibitor Id2 S Mori, SI Nishikawa, Y Yokota The EMBO journal, 2000 | 168 | 2000 |
| FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway M Asad, MK Wong, TZ Tan, M Choolani, J Low, S Mori, D Virshup, ... Cell death & disease 5 (7), e1346-e1346, 2014 | 148 | 2014 |
| Using a stem cell–based signature to guide therapeutic selection in cancer I Shats, ML Gatza, JT Chang, S Mori, J Wang, J Rich, JR Nevins Cancer research 71 (5), 1772-1780, 2011 | 143 | 2011 |
| A role for E2F6 in distinguishing G1/S-and G2/M-specific transcription PH Giangrande, W Zhu, S Schlisio, X Sun, S Mori, S Gaubatz, JR Nevins Genes & development 18 (23), 2941-2951, 2004 | 141 | 2004 |
| A genomic strategy to elucidate modules of oncogenic pathway signaling networks JT Chang, C Carvalho, S Mori, AH Bild, ML Gatza, Q Wang, JE Lucas, ... Molecular cell 34 (1), 104-114, 2009 | 139 | 2009 |
| Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer QH Miow, TZ Tan, J Ye, JA Lau, T Yokomizo, JP Thiery, S Mori Oncogene 34 (15), 1899-1907, 2015 | 132 | 2015 |
| SIRT2 down‐regulation in HeLa can induce p53 accumulation via p38 MAPK activation‐dependent p300 decrease, eventually leading to apoptosis Y Li, H Matsumori, Y Nakayama, M Osaki, H Kojima, A Kurimasa, H Ito, ... Genes to Cells 16 (1), 34-45, 2011 | 130 | 2011 |
| Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma O Gotoh, Y Sugiyama, Y Takazawa, K Kato, N Tanaka, K Omatsu, ... Nature communications 10 (1), 4965, 2019 | 127 | 2019 |
| A novel Snail-related transcription factor Smuc regulates basic helix–loop–helix transcription factor activities via specific E-box motifs H Kataoka, T Murayama, M Yokode, S Mori, H Sano, H Ozaki, Y Yokota, ... Nucleic acids research 28 (2), 626-633, 2000 | 125 | 2000 |
| High‐throughput screening in colorectal cancer tissue‐originated spheroids J Kondo, T Ekawa, H Endo, K Yamazaki, N Tanaka, Y Kukita, H Okuyama, ... Cancer science 110 (1), 345-355, 2019 | 123 | 2019 |
Tuan Zea TanCancer Science Institute of SingaporeAdresă de e-mail confirmată pe nus.edu.sg
